A

Arbutus Biopharma Corp

D
ABUS
USD
0.015
(0.3636%)
Market Closed
35,894.00
Volume
-0.46074
EPS
-
Div Yield
-9.200000
P/E
781,557,600.06
Market Cap
Today
0.3636%
1 Week
-4.167%
1 Month
9.669%
6 Months
66.265%
12 Months
109.091%
Year To Date
65.932%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
I
INO
-0.09
(-1.3294%)
USD
MRNA
MRNA
-1.79
(-2.5637%)
USD
D
DVAX
0.285
(2.5412%)
USD
N
NVAX
-0.01
(-0.0796%)
USD
S
SRNE
(%)
USD
B
BNTX
-3
(-2.5972%)
USD
VRTX
VRTX
3.93
(0.8292%)
USD
REGN
REGN
11.33
(0.9948%)
USD
GILD
GILD
0.015
(0.0179%)
USD

Title:
Arbutus Biopharma Corp

Sector:
Healthcare
Industry:
Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
Do you need help or have a question?
Contact Us